Total Payments
$2,847
2024 Payments
$141.71
Companies
14
Transactions
31
Medicare Patients
9,379
Medicare Billing
$561,581
Payment Breakdown by Category
Food & Beverage$2,786 (97.9%)
Other$60.71 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,786 | 30 | 97.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $60.71 | 1 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $845.24 | 9 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $654.15 | 7 | $0 (2022) |
| Abbott Laboratories | $223.51 | 2 | $0 (2024) |
| PFIZER INC. | $168.47 | 2 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $115.40 | 1 | $0 (2017) |
| ABBVIE INC. | $112.94 | 2 | $0 (2023) |
| Novo Nordisk Inc | $111.51 | 1 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $108.64 | 1 | $0 (2017) |
| Biohaven Pharmaceuticals, Inc. | $97.14 | 1 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $94.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $141.71 | 2 | GlaxoSmithKline, LLC. ($81.00) |
| 2023 | $292.46 | 3 | Abbott Laboratories ($162.80) |
| 2022 | $201.61 | 2 | Janssen Pharmaceuticals, Inc ($113.33) |
| 2021 | $197.50 | 2 | GlaxoSmithKline, LLC. ($100.36) |
| 2020 | $177.89 | 2 | Janssen Pharmaceuticals, Inc ($110.95) |
| 2019 | $640.56 | 7 | Janssen Pharmaceuticals, Inc ($164.22) |
| 2018 | $776.46 | 9 | GlaxoSmithKline, LLC. ($334.16) |
| 2017 | $418.35 | 4 | GlaxoSmithKline, LLC. ($122.04) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $60.71 | General |
| Category: Diabetes Care | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $81.00 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $162.80 | General |
| Category: DIABETES CARE | ||||||
| 09/14/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $113.00 | General |
| Category: RESPIRATORY | ||||||
| 06/26/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: NEUROSCIENCE | ||||||
| 07/14/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $113.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/29/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $88.28 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/30/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $97.14 | General |
| Category: PRIMARY CARE | ||||||
| 06/24/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $100.36 | General |
| Category: VACCINES | ||||||
| 02/26/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $110.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/06/2020 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $66.94 | General |
| Category: GASTROINTESTINAL | ||||||
| 12/03/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $101.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/10/2019 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $96.28 | General |
| Category: Endocrinology | ||||||
| 09/05/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $111.51 | General |
| Category: Diabetes | ||||||
| 08/15/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $101.53 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/14/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $94.68 | General |
| Category: VACCINES | ||||||
| 08/02/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $62.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/16/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $72.34 | General |
| Category: Cardiovascular | ||||||
| 10/18/2018 | Regeneron Healthcare Solutions, Inc. | PRALUENT ALIROCUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $94.00 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 10/12/2018 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $116.50 | General |
| Category: VACCINES | ||||||
| 10/11/2018 | Sanofi Pasteur Inc. | FLUZONE HIGH-DOSE (Drug), NO PRODUCT DISCUSSED | Food and Beverage | In-kind items and services | $67.13 | General |
| Category: VACCINES | ||||||
| 08/16/2018 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: VACCINES | ||||||
| 07/25/2018 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $87.79 | General |
| Category: Respiratory | ||||||
| 06/30/2018 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $101.54 | General |
| Category: VACCINES | ||||||
| 03/28/2018 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $102.20 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,468 | 4,050 | $575,801 | $168,301 |
| 2022 | 18 | 2,197 | 3,344 | $399,391 | $139,378 |
| 2021 | 22 | 2,447 | 3,806 | $393,914 | $132,782 |
| 2020 | 19 | 2,267 | 3,742 | $377,695 | $121,120 |
Total Patients
9,379
Total Services
14,942
Medicare Billing
$561,581
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 2 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 19 | 19 | $2,660 | $2,608 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 60 | 63 | $4,410 | $2,131 | 48.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 104 | 104 | $5,200 | $2,032 | 39.1% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 15 | 15 | $1,950 | $1,920 | 98.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 32 | 39 | $5,265 | $1,657 | 31.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 40 | 40 | $2,975 | $1,322 | 44.4% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 59 | 62 | $1,860 | $1,300 | 69.9% |
| 81002 | Urinalysis, manual test | Office | 2022 | 221 | 236 | $2,360 | $809.64 | 34.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 60 | 74 | $2,220 | $697.27 | 31.4% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2022 | 60 | 65 | $1,950 | $549.37 | 28.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 14 | 18 | $990.00 | $444.32 | 44.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 55 | 64 | $640.00 | $141.74 | 22.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 420 | 874 | $244,720 | $82,067 | 33.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 205 | 282 | $53,580 | $19,671 | 36.7% |
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 127 | 127 | $8,890 | $4,255 | 47.9% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2021 | 16 | 16 | $4,560 | $3,828 | 84.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 444 | 1,170 | $23,400 | $3,510 | 15.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 226 | 248 | $13,640 | $2,880 | 21.1% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 122 | 122 | $8,540 | $2,381 | 27.9% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 17 | 17 | $2,330 | $2,129 | 91.4% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 99 | 99 | $2,970 | $2,029 | 68.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 97 | 97 | $6,685 | $1,893 | 28.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 33 | 37 | $4,625 | $1,641 | 35.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 24 | 28 | $3,780 | $1,252 | 33.1% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 44 | 48 | $2,640 | $1,168 | 44.3% |
About Dr. Kerry Girard, M.D
Dr. Kerry Girard, M.D is a Internal Medicine healthcare provider based in Bridgewater, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871541045.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kerry Girard, M.D has received a total of $2,847 in payments from pharmaceutical and medical device companies, with $141.71 received in 2024. These payments were reported across 31 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($2,786).
As a Medicare-enrolled provider, Girard has provided services to 9,379 Medicare beneficiaries, totaling 14,942 services with total Medicare billing of $561,581. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Bridgewater, MA
- Active Since 05/04/2006
- Last Updated 01/12/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1871541045
Products in Payments
- XARELTO (Drug) $479.68
- BEXSERO (Biological) $312.72
- FREESTYLE LIBRE 3 (Device) $223.51
- SHINGRIX (Biological) $216.48
- AREXVY (Drug) $194.00
- INVOKANA (Drug) $174.47
- ELIQUIS (Drug) $173.87
- SHINGRIX (Drug) $122.04
- ENTRESTO (Drug) $115.40
- Ozempic (Drug) $111.51
- ZOSTAVAX (Biological) $108.64
- NURTEC ODT (Drug) $97.14
- Synthroid (Drug) $96.28
- PRALUENT ALIROCUMAB INJECTION (Biological) $94.00
- Yupelri (Drug) $88.28
- LONHALA MAGNAIR (Drug) $87.79
- FLUZONE HIGH-DOSE (Drug) $67.13
- COLOGUARD (Device) $66.94
- VRAYLAR (Drug) $16.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bridgewater
Dr. Sanjukta Sanyal, M.d, M.D
Internal Medicine — Payments: $36,192
Internal Medicine $36,192
Dr. Sharan Mahal, Md, MD
Internal Medicine — Payments: $14,948
Internal Medicine $14,948
Daniel Fung, M.d, M.D
Internal Medicine — Payments: $9,907
Internal Medicine $9,907
Dr. Alexander Kudryk, M.d, M.D
Internal Medicine — Payments: $8,689
Internal Medicine $8,689
Dr. Yimei You, M.d, M.D
Internal Medicine — Payments: $8,185
Internal Medicine $8,185
Dr. Steven Georgeson, Md, MD
Internal Medicine — Payments: $4,596
Internal Medicine $4,596